Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
MEDICAL FRONTIERS - 53rd Annual Meeting & Exposition of the American Society of Hematology
Targeted Therapies Providing Major Clinical Advances in Myeloproliferative Neoplasms
San Diego, California / December 10-13, 2011
San Diego - Progress in understanding the molecular pathophysiology of myeloproliferative neoplasms (MPNs) is generating new therapies that appear capable of inhibiting key steps in the disease process. In myelofibrosis, polycythemia vera...
PHYSICIAN PERSPECTIVE - Viewpoint based on presentations at the 53rd Annual Meeting & Exposition of the American Society of Hematology
Maintenance Therapy as an Emerging Standard for Improving Survival in Multiple Myeloma
San Diego, California / December 10-13, 2011
Reviewed and edited by: Donna E. Reece, BA, MD, FRCPCDirector, Program for Multiple Myeloma and Related Diseases Princess Margaret Hospital Associate Professor of Medicine University of Toronto Toronto, Ontario Introduction One of...
MEDI-NEWS - Based on J Clin Oncol 2011 Oct 24. [Epub ahead of print]
An Important Therapeutic Advance for Locally Advanced/ Metastatic Medullary Thyroid Carcinoma: The ZETA Trial
Despite advances in thyroid cancer treatment, neither chemotherapy nor radiation therapy has been able to improve outcomes for patients with locally advanced or metastatic medullary thyroid carcinoma (MTC). Although MTC accounts for less...
PRIORITY PRESS - 17th International Meeting of the European Society of Gynecological Oncology
Emerging Therapies for Advanced Ovarian Cancer
Milan, Italy / September 11-14, 2011
Chief Medical Editor: Dr. Léna Coïc, Montréal, Quebec Generally, platinum sensitivity refers to a platinum-free interval (PFI) >12 months. However, that definition does not address a substantial proportion of patients...
PRIORITY PRESS - 23rd Annual National Canadian Association of Nurses in Oncology Conference
Management of Catheter Occlusion and Home Intravenous Chemotherapy: Increasing Patient Safety and Comfort
Halifax, Nova Scotia / September 11-14, 2011
Halifax - It is estimated that 25% of all catheters become occluded, the majority from thrombus formation. Early recognition of a partial or complete occlusion is critical as without prompt initiation of fibrinolytic therapy, patients and...
PRIORITY PRESS - 16th Congress of the European Hematology Association (EHA)
Improving Response Rates and Duration in Patients with Multiple Myeloma
London, UK / June 9-12, 2011
London - Initially studied in the treatment of multiple myeloma patients in relapsed and refractory settings, proteasome inhibitor-based regimens have now been shown to improve outcomes in transplant-eligible and -ineligible patients with...
MEDICAL FRONTIERS - 16th Congress of the European Hematology Association (EHA)
Improving Responses to First-line Treatment in Chronic Myeloid Leukemia
London, United Kingdom / June 9-12, 2011
London - With the introduction of the first tyrosine kinase inhibitor (TKI) 10 years ago, treatment of chronic myeloid leukemia (CML) was revolutionized. Imatinib became the standard of care and in follow-up analysis of clinical trials it...
PRIORITY PRESS - 47th Annual Meeting of the American Society of Clinical Oncology (ASCO)
New Directions in Castration-resistant Prostate Cancer Management
Chicago, Illinois / June 3-7, 2011
Chief Medical Editor: Dr. Léna Coïc, Montréal, Québec Data from 5 phase III studies for the treatment of castration-resistant prostate cancer (CRPC) were presented during the 2011 ASCO annual meeting. Some...
PRIORITY PRESS - EUROGIN 2011 European Research Organization on Genital Infection and Neoplasia Congress
Reducing the Burden of HPV Disease Through Successful Vaccine Uptake
Lisbon, Portugal / May 8-11, 2011
Three years into the most successful adolescent vaccination program ever launched in Australia, a marked decline in genital warts (GWs) continues to be observed among vaccine-eligible Australian women, researchers reported during the...